SCHEMBL331105

SCHEMBL331105

C=C(COCCOCCOCCOCCO)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAOA P21397 4/20 0.40
MAOB P27338 4/20 0.40
ALDH1A1 P00352 2/20 0.39
RECQL P46063 1/20 0.39
KCNH3 Q9ULD8 1/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.35
LMNA P02545 1/20 0.34
RAB9A P51151 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
CDK1 P06493 1/20 0.34
CCNB1 P14635 1/20 0.34
MGMT P16455 1/20 0.34
CCNA2 P20248 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13295231 0.96 MAOA (0.42) SMN1; SMN2MEN1KMT2AMAOAMAOB
SCHEMBL7766571 0.85 MAOA (0.40) SMN1; SMN2MAOAMAOBALDH1A1RECQL
SCHEMBL28703837 0.84 SMN1; SMN2 (0.46) SMN1; SMN2MAOAMAOBTSHRLMNA
SCHEMBL28705220 0.84 LMNA (0.44) SMN1; SMN2KMT2AMAOAMAOBALDH1A1
SCHEMBL7768633 0.84 MAOA (0.39) SMN1; SMN2MAOAMAOBALDH1A1RECQL
SCHEMBL28693221 0.84 SMN1; SMN2 (0.46) SMN1; SMN2MAOAMAOBTSHRLMNA
SCHEMBL28684467 0.84 SMN1; SMN2 (0.42) SMN1; SMN2MEN1KMT2AMAOAMAOB
SCHEMBL3752087 0.82 MAOA (0.50) SMN1; SMN2MEN1KMT2AMAOAMAOB
SCHEMBL13792787 0.81 SMN1; SMN2 (0.40) SMN1; SMN2MEN1KMT2AMAOAMAOB
SCHEMBL28683415 0.81 TSHR (0.43) SMN1; SMN2MAOAMAOBALDH1A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537913-B1 PALLADIUM CATALYST COMPOSITION WAKO PURE CHEMICAL INDUSTIES L (JP) 2009-07-01 EP claimed
US-20060019822-A1 Palladium catalyst composition JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2006-01-26 US claimed
EP-1537913-A1 PALLADIUM CATALYST COMPOSITION Wako Pure Chemical Industies, Ltd. (JP) 2005-06-08 EP claimed
CN-117899873-A Transition metal catalyst and preparation method and application thereof 厦门大学 2024-04-19 CN disclosed
EP-1739104-B1 POLYMER-SUPPORTED METAL CLUSTER COMPOSITIONS JAPAN SCIENCE & TECH AGENCY (JP) 2014-07-09 EP disclosed
US-8110519-B2 Coordination catalyst on crosslinked catalsy support; recoverable , reuse; hydrogenation catalyst, oxidation catalyst, coupling, carbonylation JAPAN SCIENCE & TECHNOLOGY AGENCY (JP) 2012-02-07 US disclosed
US-20120029241-A1 METHOD FOR PRODUCING CARBONYL COMPOUND, CATALYST, AND METHOD FOR PRODUCING CATALYST THE UNIVERSITY OF TOKYO (JP) 2012-02-02 US disclosed
EP-2407446-A1 METHOD FOR PRODUCING CARBONYL COMPOUND, CATALYST, AND METHOD FOR PRODUCING CATALYST JX Nippon Oil & Energy Corporation (JP) 2012-01-18 EP disclosed
US-7741242-B2 Prepared by crosslinking a homogenized an addition polymer containing units from an unsaturated aryl-containing glycidyl ether or ester and an unsaturated alcohol or carboxylic acid and a zero-valent Pd compound to physically deposit the Pd compound on the polymer; oxidizing alcohols to aldehydes WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-22 US disclosed
US-7741242-B2 Prepared by crosslinking a homogenized an addition polymer containing units from an unsaturated aryl-containing glycidyl ether or ester and an unsaturated alcohol or carboxylic acid and a zero-valent Pd compound to physically deposit the Pd compound on the polymer; oxidizing alcohols to aldehydes WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-22 US disclosed
US-7741242-B2 Prepared by crosslinking a homogenized an addition polymer containing units from an unsaturated aryl-containing glycidyl ether or ester and an unsaturated alcohol or carboxylic acid and a zero-valent Pd compound to physically deposit the Pd compound on the polymer; oxidizing alcohols to aldehydes WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-22 US disclosed
US-7470646-B2 Polymer incarcerated Lewis acid metal catalyst JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2008-12-30 US disclosed
US-20080058200-A1 Polymer-Supported Metal Cluster Composition JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2008-03-06 US disclosed
US-20070197765-A1 Method of amidocarbonylation reaction JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2007-08-23 US disclosed
US-20070191624-A1 Polymer incarcerated lewis acid metal catalyst JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2007-08-16 US disclosed
EP-1739104-A1 POLYMER-SUPPORTED METAL CLUSTER COMPOSITIONS Japan Science and Technology Agency (JP) 2007-01-03 EP disclosed
EP-1738824-A1 LEWIS-ACID METAL CATALYST ENCLOSED IN POLYMER Japan Science and Technology Agency (JP) 2007-01-03 EP disclosed
EP-1731501-A1 METHOD OF AMIDOCARBONYLATION REACTION Japan Science and Technology Agency (JP) 2006-12-13 EP disclosed
US-20060019822-A1 Palladium catalyst composition JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2006-01-26 US disclosed
EP-1537913-A1 PALLADIUM CATALYST COMPOSITION Wako Pure Chemical Industies, Ltd. (JP) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029241-A1 METHOD FOR PRODUCING CARBONYL COMPOUND, CATALYST, AND METHOD FOR PRODUCING CATALYST PCCA, PPOX, COASY SMN1; SMN2 2378/4885MEN1 3360/4885KMT2A 2050/4885
US-20070191624-A1 Polymer incarcerated lewis acid metal catalyst LARS1, LIG3, LIG1 SMN1; SMN2 2063/4885MEN1 1555/4885KMT2A 1975/4885
US-20060019822-A1 Palladium catalyst composition ODC1, NUDC, ADH1C SMN1; SMN2 783/4885MEN1 2308/4885KMT2A 2594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.